Intravitreal triamcinolone acetonide in the treatment of macular retinal detachment associated with morning glory anomaly.

Published

Journal Article

PURPOSE: To report the successful treatment of a case of recurrent macular retinal detachment associated with morning glory anomaly using intravitreal triamcinolone acetonide. METHODS: A 53-year-old man with a history of bilateral morning glory anomaly and recurrent macular detachment of the left eye refractory to multiple surgical interventions, including 3 vitrectomies with endolaser photocoagulation, gas tamponade, and fibrin glue, underwent an intravitreal injection of 4 mg triamcinolone acetonide. RESULTS: A single treatment with intravitreal triamcinolone acetonide resulted in resolution of a macular retinal detachment and intraretinal fluid within 2 weeks. CONCLUSION: Treatment with intravitreal triamcinolone acetonide may be beneficial in cases of macular retinal detachment associated with morning glory anomaly.

Full Text

Duke Authors

Cited Authors

  • Lee, AC; Haller, JA; Jaegers, KR; McCuen, BW

Published Date

  • 2009

Published In

Volume / Issue

  • 3 / 4

Start / End Page

  • 333 - 335

PubMed ID

  • 25389840

Pubmed Central ID

  • 25389840

International Standard Serial Number (ISSN)

  • 1935-1089

Digital Object Identifier (DOI)

  • 10.1097/ICB.0b013e318196b2a1

Language

  • eng

Conference Location

  • United States